Loading clinical trials...

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice | Clinical Trials | Clareo Health

RECRUITING

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

a Non-randomized, Prospective, Open-label Registry to Compare the Effectiveness and Safety of XIENCE Skypoint™ Stents Versus Other DESs in Patients With Coronary Artery Disease

NCT05981911•Seung-Jung Park

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the effectiveness and safety of XIENCE Skypoint stents in comparison to other drug-eluting stents (DES) in real-world practice.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Patients ≥ 19 years old
•2. Patients receiving Xience-Skypoint™ stents.
•3. The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion Criteria

•1. Patients with a mixture of other DESs
•2. Terminal illness with life expectancy \<1 year
•3. Patients with cardiogenic shock

Locations (1)

Asan Medical Hospital

Seoul, South Korea

Key Dates

Start Date

December 14, 2023

Primary Completion Date

June 1, 2026

Completion Date

December 1, 2026

Last Updated

January 2, 2026

Enrollment

2,000

ESTIMATED participants

Conditions

Coronary Artery Disease

Interventions

XIENCE Skypoint™ stent

DEVICE

Contacts

Jung-hee Ham, Project manager

CONTACT

82230104728 cvcrc5@amc.seoul.kr

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 2, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluation of Effectiveness and Safety of Xience Skypoint Stents in Routine Clinical Practice

Inclusion Criteria

Exclusion Criteria

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

"Erectile Function After PCI in MI and Non-MI Patients"

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Product Surveillance Registry

Essential Pro Study ( rEPIC04E-HK )

Factors Affect Outcomes in Cardiovascular Surgery